Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimer…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Allogene Therapeutics, Inc. (ALLO) to it's peer group.
Peer Group
BPMC NTLA BEAM MRTX RLAY LIFE SGMO SANA HRTX ICVX GTHX VERV ANNX ITOS CRBU IPSC EDIT PRME THRX
Compare Together
Loading...